Search Contract Opportunities

Germline PGx Services (VA-24-00021530)   6

ID: 36C10X24R0051 • Type: Presolicitation

Description

Presolicitation Notice Presolicitation Notice Page 3 of 3 Presolicitation Notice *=Required Field Presolicitation Notice Page 1 of 3 SUBJECT* Veterans Health Administration (VHA) National Oncology Program-Germline / Pharmacogenomics Molecular Testing IDIQ GENERAL INFORMATION CONTRACTING OFFICE S ZIP CODE* 21703 SOLICITATION NUMBER* 36C10X24R0051 RESPONSE DATE/TIME/ZONE 06-14-2024 15:00 EASTERN TIME, NEW YORK, USA ARCHIVE 60 DAYS AFTER THE RESPONSE DATE SET-ASIDE PRODUCT SERVICE CODE* Q301 NAICS CODE* 621511 PLACE OF PERFORMANCE Contracting facility POSTAL CODE COUNTRY USA CONTACT INFORMATION CONTRACTING OFFICE ADDRESS Strategic Acquisition Center - Frederick Department of Veterans Affairs 5202 Presidents Court, Suite 103 Frederick MD 21703 POINT OF CONTACT* Contracting Specialist Mr. LaShawn Knight Lashawn.knight@va.gov ADDITIONAL INFORMATION AGENCY S URL URL DESCRIPTION AGENCY CONTACT S EMAIL ADDRESS EMAIL DESCRIPTION DESCRIPTION This is a Pre-Solicitation announcement to inform potential offerors of the Department of Veterans Affairs' intent to solicit a Request for Proposal (RFP) for national access to germline genetic testing for Oncology and Medical Genetics and pharmacogenomic testing for patients eligible to receive care throughout the VA enterprise. This will be in accordance with the testing guidance established by the National Oncology Program (NOP), the National Genomic Medicine Program (GMP), and the National Pharmacogenomics Program (NPP). Potential offerors shall provide all personnel, equipment, supplies, facilities, tools, materials, supervision, trainings, and other items and services necessary, as defined in the Performance Work Statement (PWS), except for those items specified as government-furnished property and services. Potential offerors shall perform to the standards in this contract and maintain compliance with policies and procedures with the Health Insurance Portability and Accountability Act (HIPAA), the Clinical Laboratory Improvement Act (CLIA), and accreditation with the American College of Medical Genetics and Genomics (ACMG), the College of American Pathologists (CAP), or the Joint Commission (JC), and maintain the relevant laboratory and personnel state licensure to offer testing across the United States and its territories. The potential offeror s laboratory shall have the ability to perform collection kit delivery, sample intake, processing, analysis, interpretation, reflex testing, and reporting for one or more germline genetic tests and pharmacogenomic (PGx) tests, as described herein. The potential offeror must demonstrate the capacity to service all VA Oncology, Medical Genetics, and Pharmacogenomics practice sites (>170) including growth as additional Medical Centers and other practice sites needing testing services (in all 50 states and US territories). It is the intent of the Government to award multiple IDIQ contracts under FAR Part 16.5, with Firm Fixed-Price (FFP) task orders to be awarded. The Government reserves the right to establish as many or as few contracts as deemed appropriate based on the results of this competition. The IDIQ Contracting Officer has determined that an IDIQ was the best way to procure these services due to the various testing services required to fill repetitive needs from VHA throughout the VA. The FAR 16.505 fair opportunity process will ensure adequate price competition, allowing the Contracting Officer to establish fair and reasonable pricing. North American Industry Classification System (NAICS) Code 621511 Medical Laboratories is most appropriate for this requirement. The size standard is $41.5M. The Product Service Code (PSC) is Q301. This requirement is intended to be unrestricted and is not a set-aside. This notice is for informational purposes only and is not a request for submission of offers. No other information regarding scope, dates, etc., is available until the issuance of the solicitation via Contract Opportunities at SAM.gov. If a solicitation is issued, information will be posted on the FedBizOpps (FBO) website for all qualified interested parties at a later date and interested parties must respond to the solicitation to be considered for award. This notice does not commit the government to contract for any supplies or services. Address all questions in writing to Contract Specialist, LaShawn Knight, lashawn.knight@va.gov, and Jacky Jean-Jacques, jacky.jean-jacques@va.gov.
Background
This is a Pre-Solicitation announcement to inform potential offerors of the Department of Veterans Affairs' intent to solicit a Request for Proposal (RFP) for national access to germline genetic testing for Oncology and Medical Genetics and pharmacogenomic testing for patients eligible to receive care throughout the VA enterprise. This will be in accordance with the testing guidance established by the National Oncology Program (NOP), the National Genomic Medicine Program (GMP), and the National Pharmacogenomics Program (NPP).

Work Details
Potential offerors shall provide all personnel, equipment, supplies, facilities, tools, materials, supervision, trainings, and other items and services necessary, as defined in the Performance Work Statement (PWS), except for those items specified as government-furnished property and services. Potential offerors shall perform to the standards in this contract and maintain compliance with policies and procedures with the Health Insurance Portability and Accountability Act (HIPAA), the Clinical Laboratory Improvement Act (CLIA), and accreditation with the American College of Medical Genetics and Genomics (ACMG), the College of American Pathologists (CAP), or the Joint Commission (JC), and maintain the relevant laboratory and personnel state licensure to offer testing across the United States and its territories.

The potential offeror’s laboratory shall have the ability to perform collection kit delivery, sample intake, processing, analysis, interpretation, reflex testing, and reporting for one or more germline genetic tests and pharmacogenomic (PGx) tests.

Place of Performance
Contracting facility in Frederick MD 21703

Overview

Response Deadline
June 14, 2024, 3:00 p.m. EDT Past Due
Posted
June 5, 2024, 6:26 p.m. EDT
Set Aside
None
Place of Performance
Frederick, VA 21703 USA
Source
SAM

Current SBA Size Standard
$41.5 Million
Pricing
Fixed Price
Est. Level of Competition
Low
Est. Value Range
Experimental
$5,000,000 - $20,000,000 (AI estimate)
Odds of Award
65%
Vehicle Type
Indefinite Delivery Contract
Signs of Shaping
The solicitation is open for 8 days, below average for the Strategic Acquisition Center Frederick.
On 6/5/24 Strategic Acquisition Center Frederick issued Presolicitation 36C10X24R0051 for Germline PGx Services (VA-24-00021530) due 6/14/24. The opportunity was issued full & open with NAICS 621511 and PSC Q301.
Primary Contact
Title
Contract Specialist
Name
LaShawn A Knight   Profile
Phone
(302) 287-6554

Documents

Posted documents for Presolicitation 36C10X24R0051

Question & Answer

Opportunity Lifecycle

Procurement notices related to Presolicitation 36C10X24R0051

Award Notifications

Agency published notification of awards for Presolicitation 36C10X24R0051

IDV Awards

Indefinite delivery vehicles awarded through Presolicitation 36C10X24R0051

Incumbent or Similar Awards

Contracts Similar to Presolicitation 36C10X24R0051

Potential Bidders and Partners

Awardees that have won contracts similar to Presolicitation 36C10X24R0051

Similar Active Opportunities

Open contract opportunities similar to Presolicitation 36C10X24R0051

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > SAC FREDERICK (36C10X)
FPDS Organization Code
3600-0010X
Source Organization Code
100173467
Last Updated
Aug. 13, 2024
Last Updated By
Lashawn.Knight@va.gov
Archive Date
Aug. 13, 2024